Author:
Costa Gustavo N. O.,Magno Luiz A. V.,Santana Cinthia V. N.,Konstantinovas Cibele,Saito Samuel T.,Machado Moara,Di Pietro Giuliano,Bastos-Rodrigues Luciana,Miranda Débora M.,De Marco Luiz A.,Romano-Silva Marco A.,Rios-Santos Fabrício
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology,Genetics,Molecular Medicine,General Medicine
Reference40 articles.
1. Balasingham SV, Davidsen T, Szpinda I, et al. Molecular diagnostics in tuberculosis: basis and implications for therapy. Mol Diagn Ther 2009; 13 (3): 137–51.
2. Marra F, Marra CA, Bruchet N, et al. Adverse drug reactions associated with first-line anti-tuberculosis drug regimens. Int J Tuberc Lung Dis 2007 Aug; 11 (8): 868–75.
3. Steffen R, Menzies D, Oxlade O, et al. Patients’ costs and cost-effectiveness of tuberculosis treatment in DOTS and non-DOTS facilities in Rio de Janeiro, Brazil. PLoS ONE 2010; 5 (11): e14014.
4. Phillips KA, Veenstra DL, Oren E, et al. Potential role of pharmacogenomics in reducing adverse drug reactions: a systematic review. JAMA 2001 Nov; 286 (18): 2270–9.
5. Parkin DP, Vandenplas S, Botha FJ, et al. Trimodality of isoniazid elimination: phenotype and genotype in patients with tuberculosis. Am J Respir Crit Care Med 1997 May; 155 (5): 1717–22.
Cited by
20 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献